| Literature DB >> 35573798 |
Huimin Bai1, Jing Yang2, Shu Meng1, Chengcheng Liu1.
Abstract
The oral cavity harbors approximately 1,000 microbial species, and both pathogenic and commensal strains are involved in the development of carcinogenesis by stimulating chronic inflammation, affecting cell proliferation, and inhibiting cell apoptosis. Moreover, some substances produced by oral bacteria can also act in a carcinogenic manner. The link between oral microbiota and chronic inflammation as well as cell proliferation has been well established. Recently, increasing evidence has indicated the association of the oral microbiota with cell migration, which is crucial in regulating devastating diseases such as cancer. For instance, increased cell migration induced the spread of highly malignant cancer cells. Due to advanced technologies, the mechanistic understanding of cell migration in carcinogenesis and cancer metastasis is undergoing rapid progress. Thus, this review addressed the complexities of cell migration in carcinogenesis and cancer metastasis. We also integrate recent findings on the molecular mechanisms by which the oral microbiota regulates cell migration, with emphasis on the effect of the oral microbiota on adhesion, polarization, and guidance. Finally, we also highlight critical techniques, such as intravital microscopy and superresolution microscopy, for studies in this field.Entities:
Keywords: EMT; carcinogenesis; cell migration; metastasis; oral microbiota
Mesh:
Year: 2022 PMID: 35573798 PMCID: PMC9103474 DOI: 10.3389/fcimb.2022.864479
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 6.073
Summary of oral bacteria affecting cell migration.
| Bacteria species | Cell types | Infection conditions | Effect on cell migration | Ref |
|---|---|---|---|---|
|
| human immortalized oral epithelial cells (HIOECs) | MOI=1, 24 h | promote | ( |
| primary human oral epithelial cells (OECs) | MOI=10 and 100, 120 h | promote | ( | |
| primary gingival keratinocytes | MOI=10, 24 h | inhibit | ( | |
| Human telomerase immortalized gingival keratinocytes (TIGK) | MOI=100,1 h, followed by 23 h in fresh medium | promote | ( | |
| TIGK | MOI=100, 24 h | promote | ( | |
| Human immortalized oral keratinocyte cell line OKF6/hTERT-1 | MOI=100, 24 h | promote | ( | |
| human OSCC cell lines, UM-SCC-14A (floor of mouth) and HSC-3 (tongue) | MOI=10,50,100,2 h | promote | ( | |
| SAS and Ca9-22 cells | MOI=1, 24 h | promote | ( | |
| OSC-20 and SAS cells | MOI=100,3 h | promote | ( | |
| Human esophageal cancer cell lines NE6-T, KYSE-30 and KYSE-150 | MOI=10, 48 h | promote | ( | |
| secreted gingipains of | human embryonic microglia clone 3 (HMC3) cell line | MOI=1,12 h | promote | ( |
| Outer membrane vesicles (OMVs) of | OSCC cell line (HSC-3) | 6 h | promote | ( |
| Ltp1 of | TIGK | MOI=100, 6 h | promote | ( |
| Heat-killed | OSCC cell line(H400) | MOI=100, 8 d | promote | ( |
|
| human buccal epithelial cell line HO-1-N-1 | MOI=10,100, 17 h | inhibit | ( |
| heat-killed | human buccal epithelial cell line HO-1-N-1 | MOI=100, 1000,17 h | inhibit | ( |
| conditioned medium from | human buccal epithelial cell line HO-1-N-1 | MOI=100,17 h | inhibit | ( |
|
| Ca9-22 OSCC cells | MOI=100, 2 h | promote | ( |
|
| primary gingival keratinocytes | MOI=10:1, 24 h | inhibit | ( |
| human OSCC cell lines, UM-SCC-14A (floor of mouth) and HSC-3 (tongue) | MOI=10,50,100,2 h | promote | ( | |
| Colorectal cancer cell lines (HCT-116, LoVo) | MOI=100, 12 h and 24 h | promote | ( | |
| Heat-killed | OSCC cell line(H400) | MOI=100, 8 d | promote | ( |
| OSCC cell line(HOC621 cells) | MOI=10, 3 h | promote | ( | |
| Heat-killed | OSCC cell line(HOC621 cells) | MOI=10, 3 h | promote | ( |
| Live or heat-killed | OSCC cell line(HOC621 cells) | MOI=10, 3 h | promote | ( |
| Live or heat-killed | OSCC cell line(HOC621 cells) | MOI=10, 3 h | promote | ( |
|
| human OSCC cell lines, UM-SCC-14A (floor of mouth) and HSC-3 (tongue) | MOI=10,50,100,2 h | promote | ( |
|
| human buccal epithelial cell line HO-1-N-1 | MOI=10,100 or 1000, 17 h | inhibit | ( |
Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model.
Figure 1Possible mechanisms by which oral microbiota influence cell migration. P. gingivalis and HPV 16 release intercellular adhesions by downregulating E-cadherin and upregulating MMP. P. gingivalis enhances the expression of Cdc42 and Rac2 to induce the front and back polarity that is crucial for cell migration. P. gingivalis drives cell clusters to move orientally through the formation of integrin and focal adhesion.
Figure 2Oral microbiota guide epithelial-mesenchymal transition of normal epithelial cells. EMT-associated transcription factors (Zeb1, Zeb2, Slug, Snail, Jag1, Notch, Twist, OLFM4 and RGCC) can induce epithelial cells to undergo partial or complete mesenchymal transformation by downregulating epithelial markers (such as E-cadherin) and upregulating mesenchymal markers (MMP and Vimentin). P. gingivalis and F. nucleatum enhance the expression of EMT-associated transcription factors through diverse pathways: (1) the phosphorylation of GSK‐3β, EGF, TNF-α and TGF-β1; (2) the activation of the IL-6/STAT3 pathway; (3) the upregulation of NNMT, CCAT1 and GAS6;(4) the nuclear translocation of β-catenin and further activation TCF/LEF promoter elements; (5) the activation of PTEN; and (6) the upregulation of FOXO1 S. gordonii can resist EMT-associated factor induction by P. gingivalis by suppressing FOXO1 and activating the TAK1-NLK negative regulatory pathway.